Cardiac amyloidosis describes clinically significant involvement of the heart by amyloid deposition, which may or may not be associated with involvement of other organs. The purpose of this review is to summarize the current state of evidence for the effective evaluation and management of cardiac amyloidosis. Acquired systemic amyloidosis occurs in more than 10 per million person-years in the U.S. population. Although no single noninvasive test or abnormality is pathognomonic of cardiac amylo...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Evaluation and management of the cardiac amyloidosis.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record